Computational Biology Market Reduces the Number of Human Candidates Required to Test Drugs in Development Stage
A number of drug candidates failing in late-stage clinical trials has brought to the fore the importance of computational biology; this will help the global computational biology market reach a valuation of US$2.9 bn by 2018, rising rapidly from its 2011 valuation of US$0.7 bn, says Transparency Market Research. In its report, titled 'Computational Biology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018', the market intelligence firm also states that the computational biology market...
View full press release